Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases
Irene Reyes‐Resina, Gemma Navarro, David Aguinaga, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 169-179
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Thian‐Sze Wong, Guangzhi Li, Shiliang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 60
The synthetic cannabinoids menace: a review of health risks and toxicity
Ayman Alzu’bi, Fatimah Almahasneh, Ramada R. Khasawneh, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 21
Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling
Gemma Navarro, Marc Gómez‐Autet, Paula Morales, et al.
Pharmacological Research (2024) Vol. 208, pp. 107363-107363
Open Access | Times Cited: 15
The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders
Juliette Giacobbe, Bonnie Benoiton, Patricia A. Zunszain, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 113
A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz, Katarzyna Znajdek, Monika Grudzień, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2778-2778
Open Access | Times Cited: 102
The cannabinoid system and microglia in health and disease
Samuel S. Duffy, Jessica P. Hayes, Nathan T. Fiore, et al.
Neuropharmacology (2021) Vol. 190, pp. 108555-108555
Closed Access | Times Cited: 71
Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
Giulia Abate, Daniela Uberti, Simone Tambaro
Biology (2021) Vol. 10, Iss. 6, pp. 542-542
Open Access | Times Cited: 71
Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target
Mengmeng Zhao, Zihui Zheng, Zheng Yin, et al.
Pharmacological Research (2023) Vol. 195, pp. 106832-106832
Open Access | Times Cited: 18
Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists
Rafael Franco, Irene Reyes‐Resina, David Aguinaga, et al.
Glia (2019) Vol. 67, Iss. 12, pp. 2410-2423
Closed Access | Times Cited: 47
Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?
Paula Morales, Ana Lago-Fernandez, Dow P. Hurst, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14216-14227
Open Access | Times Cited: 44
Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer’s, Parkinson’s, and Huntington’s Diseases
Catalina Pérez-Olives, Rafael Rivas‐Santisteban, Jaume Lillo, et al.
Advances in experimental medicine and biology (2020), pp. 81-92
Closed Access | Times Cited: 43
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids
Rafael Franco, Rafael Rivas‐Santisteban, Irene Reyes‐Resina, et al.
Pharmacological Research (2020) Vol. 158, pp. 104801-104801
Closed Access | Times Cited: 40
Two-Step Cell Death Induction by the New 2-Arachidonoyl Glycerol Analog and Its Modulation by Lysophosphatidylinositol in Human Breast Cancer Cells
Mikhail Akimov, N. M. Gretskaya, Evgenia I. Gorbacheva, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 820-820
Open Access
Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors
Iu Raïch, Rafael Rivas‐Santisteban, Alejandro Lillo, et al.
Pharmacological Research (2021) Vol. 174, pp. 105970-105970
Open Access | Times Cited: 29
Resolvin D2 limits atherosclerosis progression via myeloid cell‐GPR18
Masharh Lipscomb, Sean Walis, Michael Marinello, et al.
The FASEB Journal (2024) Vol. 38, Iss. 6
Closed Access | Times Cited: 4
Membrane Heteroreceptor Complexes as Second-Order Protein Modulators: A Novel Integrative Mechanism through Allosteric Receptor–Receptor Interactions
Marina Mirchandani‐Duque, Malak Choucri, Juan C. Hernández-Mondragón, et al.
Membranes (2024) Vol. 14, Iss. 5, pp. 96-96
Open Access | Times Cited: 4
Multilayered neuroprotection by cannabinoids in neurodegenerative diseases
Ahmed Hasbi, Susan R. George
Exploration of Neuroprotective Therapy (2025) Vol. 5
Open Access
Multilayered neuroprotection by cannabinoids in neurodegenerative diseases
Ahmed Hasbi, Susan R. George
Exploration of Neuroprotective Therapy (2025) Vol. 5
Open Access
Novel approaches and current challenges with targeting the endocannabinoid system
Paula Morales, Nadine Jagerovic
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 8, pp. 917-930
Open Access | Times Cited: 30
Endocannabinoid signaling pathways: beyond CB1R and CB2R
Roger G. Biringer
Journal of Cell Communication and Signaling (2021) Vol. 15, Iss. 3, pp. 335-360
Open Access | Times Cited: 24
The Interaction of the Endocannabinoid Anandamide and Paracannabinoid Lysophosphatidylinositol during Cell Death Induction in Human Breast Cancer Cells
Mikhail Akimov, N. M. Gretskaya, Evgenia I. Gorbacheva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2271-2271
Open Access | Times Cited: 3
Unraveling the Mechanisms of Cannabidiol’s Pharmacological Actions: A Comprehensive Research Overview
Iqra Kalsoom, Kiran Shehzadi, Hansheng Li, et al.
Topics in Current Chemistry (2024) Vol. 382, Iss. 2
Closed Access | Times Cited: 3
N-Methyl-D-aspartate (NMDA) and cannabinoid CB2 receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA receptors
Rafael Rivas‐Santisteban, Alejandro Lillo, Jaume Lillo, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Receptor-Dependent and Independent Regulation of Voltage-Gated Ca2+ Channels and Ca2+-Permeable Channels by Endocannabinoids in the Brain
Tomasz Boczek, Ludmiła Żylińska
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8168-8168
Open Access | Times Cited: 20
Endocannabinoid-Binding Receptors as Drug Targets
María Gómez‐Cañas, Carmen Rodríguez‐Cueto, Valentina Satta, et al.
Methods in molecular biology (2022), pp. 67-94
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top